Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Alemany

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Cancer Gene Therapy|June 18, 2019
Enhanced antitumor efficacy of an oncolytic adenovirus armed with an EGFR-targeted BiTE using menstrual blood-derived mesenchymal stem cells as carriersPaula Barlabé, Jana de Sostoa, Carlos Alberto Fajardo, et al.
Current Gene Therapy|October 29, 2009
Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomasHong Jiang, Candelaria Gomez-Manzano, Frederick F Lang, et al.
Human Gene Therapy|September 16, 2006
Deletion of VAI and VAII RNA genes in the design of oncolytic adenovirusesManel Cascallo, Alena Gros, Neus Bayo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2019
IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1Emma Eriksson, Ioanna Milenova, Jessica Wenthe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2010
Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growthSonia Guedan, Juan José Rojas, Alena Gros, et al.
Neoplasia (New York, N.Y.)|June 2, 2009
Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse modelsMeritxell Huch, Alena Gros, Anabel José, et al.
Cancer Research|August 17, 2002
Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoterDirk M Nettelbeck, Angel A Rivera, Cristina Balagué, et al.
The Journal of General Virology|August 9, 2006
Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargetingNeus Bayo-Puxan, Manel Cascallo, Alena Gros, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Verapamil enhances the antitumoral efficacy of oncolytic adenovirusesAlena Gros, Cristina Puig, Sonia Guedan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2018
Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic CancerMaria Rovira-Rigau, Giulia Raimondi, Miguel Ángel Marín, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Cancer Gene Therapy|June 18, 2019
Enhanced antitumor efficacy of an oncolytic adenovirus armed with an EGFR-targeted BiTE using menstrual blood-derived mesenchymal stem cells as carriersPaula Barlabé, Jana de Sostoa, Carlos Alberto Fajardo, et al.
Current Gene Therapy|October 29, 2009
Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomasHong Jiang, Candelaria Gomez-Manzano, Frederick F Lang, et al.
Human Gene Therapy|September 16, 2006
Deletion of VAI and VAII RNA genes in the design of oncolytic adenovirusesManel Cascallo, Alena Gros, Neus Bayo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2019
IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1Emma Eriksson, Ioanna Milenova, Jessica Wenthe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2010
Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growthSonia Guedan, Juan José Rojas, Alena Gros, et al.
Neoplasia (New York, N.Y.)|June 2, 2009
Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse modelsMeritxell Huch, Alena Gros, Anabel José, et al.
Cancer Research|August 17, 2002
Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoterDirk M Nettelbeck, Angel A Rivera, Cristina Balagué, et al.
The Journal of General Virology|August 9, 2006
Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargetingNeus Bayo-Puxan, Manel Cascallo, Alena Gros, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Verapamil enhances the antitumoral efficacy of oncolytic adenovirusesAlena Gros, Cristina Puig, Sonia Guedan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2018
Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic CancerMaria Rovira-Rigau, Giulia Raimondi, Miguel Ángel Marín, et al.
Pageof 11